NCT01633749View on ClinicalTrials.gov

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2012/2013 Season

PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Prophylaxis of Influenza

Interventions

BIOLOGICAL

Trivalent influenza subunit vaccine Influvac

3x 15mcg HA per 0.5 ml,trivalent one injection at Day 1

Trial Locations (1)

22769

Site Reference ID/Investigator# 74593, Hamburg

Sponsors

Lead Sponsor

Abbott Biologicals

All Listed Sponsors

lead

Abbott Biologicals

INDUSTRY

NCT01633749 - Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2012/2013 Season | Biotech Hunter | Biotech Hunter